You are about to leave the site and are being redirected to another site.

Would you like to leave this site?

The ONC Patient Assistance Program

ONC includes a Patient Assistance Program (PAP) that provides TEPMETKO® (tepotinib) at no charge to patients who meet certain insurance (i.e., uninsured), income, and residency eligibility criteria.

  • To determine patient eligibility, providers should complete and fax the ONC Enrollment Form prior to treatment to 1-844-501-0062
  • An Access Navigator will notify you as soon as possible about the patient’s eligibility status
  • If eligible, the ONC PAP will ship the free supply of TEPMETKO to the patient

Note: The ONC PAP is a support program for patients in need and is not contingent on any past or future commercial sale of TEPMETKO.

This site is intended only for US residents 18 years of age or older

TERMS OF USE     PRIVACY POLICY     CONTACT US     SITE MAP     COOKIES SETTINGS

US-TEP-00448     January 2022
© 2021 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. TEPMETKO is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.